New guidelines in UK could accelerate clinical trials

MHRA’s new guidance on using real-world data to support clinical trials could get medicines to patients sooner

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) changed its guidelines to allow the use of “real-world data” collected from the healthcare system to aid in regulatory approval of new medicines. This will expedite clinical trials and get treatments to patients sooner!

PDF of article